A phase 1 multicenter study evaluating the safety and efficacy of MHC class II-restricted MAGE-A3/A6 T-cell receptor engineered T cells (KITE-718) in patients with advanced cancers Meeting Abstract
| Authors: | Kebriaei, P.; Klebanoff, C. A.; Creelan, B. C.; Hong, D. S.; Blumenschein, G. R.; Drakaki, A.; Tewari, A.; Thomrongsith, L.; Jiang, Y.; Jain, R. K. |
| Abstract Title: | A phase 1 multicenter study evaluating the safety and efficacy of MHC class II-restricted MAGE-A3/A6 T-cell receptor engineered T cells (KITE-718) in patients with advanced cancers |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 162s |
| Language: | English |
| ACCESSION: | WOS:000442916007571 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS3104 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS3104 -- Source: Wos |
